Particle Therapy 2017

HCC Conclusions (1)

•

> 80% of pa+ents not operable at diagnosis

•

PEI, RFA, TACE: specific pa+ent selec+on criteria

•

SBXT

–

One-year survival: 48-94%

–

Local control: 65-86%

–

Grade 4-5 toxicity between 0 and 6%; RILD up to 18%

•

X-raytherapy is limited by dose to diseased liver

•

Par+cle therapy (similar for p and C)

–

5-year survival 36.3-48%

–

Local control: 81-93%

–

Acute and late severe toxicity: <3%